SCHD's 2026 Reconstitution — What UNH and Qualcomm In, AbbVie and Cisco Out Actually Mean
SCHD's 2026 Reconstitution — What UNH and Qualcomm In, AbbVie and Cisco Out Actually Mean
TL;DR SCHD's 2026 reconstitution removed 22 holdings and added 25 new ones. AbbVie and Cisco Systems are out. United Health (UNH) and Qualcomm (QCOM) are in. The top sector shifted from energy to consumer staples and healthcare. For portfolios heavy in tech, SCHD remains the most effective balancer available.
The Schwab US Dividend Equity ETF, ticker SCHD, is one of the most widely held dividend funds among income investors. Its 2026 annual reconstitution just wrapped up and the portfolio has meaningfully shifted.
What caught my eye most was the sector rotation. A year ago energy held the top spot. Now consumer staples and healthcare sit at the top. Longtime dividend names like AbbVie got dropped while United Health and Qualcomm were added. That is not coincidence.
What Changed — 22 Out, 25 In
The key numbers from this reconstitution:
- Removed: 22 holdings (notable names include AbbVie, Cisco Systems, several retail names)
- Added: 25 holdings (notably United Health Group and Qualcomm)
- Top sector shift: energy → consumer staples + healthcare
- Materials and real estate: largely or entirely excluded
AbbVie is a quality dividend name with a strong drug pipeline. The issue is the stock ran too far too fast. Yield compressed below SCHD's effective threshold of roughly 3 percent. SCHD is not a momentum strategy that lets winners ride. It is a buy-the-dip strategy driven by quantitative screens. When valuation stretches, the screen drops the name.
Cisco Systems tells the same story. SCHD has very limited room for tech in the first place, and stocks that rode the AI narrative higher tend to lose their dividend appeal.
Why UNH and Qualcomm Got Added
UNH is the addition I find most interesting. Persistent weakness in the stock compressed its valuation, and that compression is precisely what pushed it through SCHD's quantitative screens. Regulatory and medical-cost risks still exist, but much of that risk is now priced in at current levels. That is effectively what the SCHD inclusion is signaling.
Qualcomm replaces Cisco in the tech slice. Qualcomm has lagged the broader AI and chip rally, which pushed its dividend yield and valuation profile back into SCHD territory.
Both additions share one trait. They are not narrative winners. They are names left behind. That is SCHD's entire philosophy in a single observation.
How SCHD Actually Works
SCHD uses a fully rules-based selection process. No human override.
- Baseline requirement: 10 consecutive years of dividend payments, minimum market cap around 500 million dollars
- Quantitative filters: cash flow to debt, ROE, dividend yield, 5-year dividend growth
- Selection: filter survivors ranked by dividend yield, top ~100 selected
- Rebalance cap: single-name weight capped at 4 percent, trimmed quarterly
- Reconstitution: once a year
Note the rule is 10 consecutive years of payments, not increases. The bar is lower than Dividend Kings or Aristocrats. The final ranking is by dividend yield, which means higher-yielding survivors win spots.
What This Means
Consumer staples and healthcare climbing to the top signals a more defensive posture for the ETF. The algorithm is quietly saying: "prepare for slower growth." SCHD does not forecast individual stocks. It rotates automatically toward companies with strong cash flow and dividend track records that also happen to be cheap.
Other dividend ETFs like VIG (Vanguard Dividend Appreciation) and DGRO (iShares Core Dividend Growth) carry more tech exposure. If you already hold a dividend ETF, audit what exposure you are actually getting. Overlapping tech exposure turns "diversification" into concentrated betting by another name.
What to Watch
The real test is how this reconstitution shows up in 12-month returns. The energy-heavy 2025 version of SCHD lagged during energy weakness and rebounded with energy's recovery. The 2026 version is weighted toward staples and healthcare, so those sectors will drive performance from here.
My one-line take — SCHD remains the most efficient balancer for a growth-heavy portfolio. If you already hold QQQ, an AI ETF, and a cybersecurity ETF, you need a tool with non-overlapping exposure. This reconstitution sharpens that balancing function rather than weakening it.
Next Posts
The 10% Rule and the Over-Diversification Trap — Why You Need Balance, Not Diversification
The 10% Rule and the Over-Diversification Trap — Why You Need Balance, Not Diversification
Diversification should not be the goal — risk-adjusted capital efficiency should. Cap single-stock positions at 10% of total portfolio (ETFs exempt), scale position count to time spent on the market, and treat equal-weight across 11 sectors as over-diversification. Balance is a survival strategy, not a prediction.
S&P 500 Is 34% Tech — Is It Still Safe? How SCHD Restores the Balance
S&P 500 Is 34% Tech — Is It Still Safe? How SCHD Restores the Balance
Over 34% of the S&P 500 is concentrated in tech, with the top 10 holdings making up more than a third of the index. Six decades of data show no negative 20-year rolling window, but today's concentration breaks the "500-stock diversification" assumption. Hold the S&P 500 as core and balance with a sector-neutral tool like SCHD.
Amazon (AMZN) at $2.28T — The AI Capex Gap and Why I Wait for $200
Amazon (AMZN) at $2.28T — The AI Capex Gap and Why I Wait for $200
Amazon market cap $2.28T, net income $77.7B vs free cash flow $7.7B — a 10x gap driven by AWS and AI infrastructure capex. 10-year DCF fair value range $110-$497 (mid $250). Current $237 offers insufficient margin of safety. Personal buy trigger at $200.
Previous Posts
The Truth About Low-Volume Bull Markets — 4 Historical Cases That Disprove the Narrative
The Truth About Low-Volume Bull Markets — 4 Historical Cases That Disprove the Narrative
The social-media narrative that "low volume = weakness" breaks down against historical data. The December 2024 post-election rally and all of 2024 climbed on low volume. What matters is combining volume with price levels — volume is decisive only at reversals and breakouts.
NVDA vs AVGO vs AMD — Who Is the Real Winner of the Semiconductor Rally?
NVDA vs AVGO vs AMD — Who Is the Real Winner of the Semiconductor Rally?
With SMH ripping above 428, NVDA settled near 200, AVGO cleared 386–387 eyeing 402 and all-time highs, and AMD pushes toward 300 above 267. Combining fundamentals and technicals, AVGO looks most attractive; AMD is suitable only for short-term trades.
QQQ and SPY Reclaim All-Time Highs — 90 EMA Playbook and the Next Buy Zone
QQQ and SPY Reclaim All-Time Highs — 90 EMA Playbook and the Next Buy Zone
QQQ cleared 628–629 and ripped straight up yesterday; today delivered a textbook bounce on the prior-ATH retest. SPY holds the bullish bias above 697. The 5-min and 15-min 90 EMA is the most reliable short-term tool, with a 697–698 retest offering the cleanest re-entry setup.